Mapping AF Mechanisms is Required for Successful Ablation of Persistent AF (debate / rebuttals)

  • Description
  • CME Info
  • Faculty

Persistent AF ablation is at another crossroads. Do you think PVI alone is sufficient, in which case why map? Instead perhaps you feel that a fixed lesion set is always indicated. Or do any of the patient specific AF mapping tools offer real insight into fundamental mechanisms to target?

This debate session is 45 minutes in length and is comprised of one chair and two invited speakers. Each speaker has up to 15 minutes to present their case followed by a five minute rebuttal.

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Chair - Gerhard Hindricks, MD. Heart Center - University of Leipzig, Leipzig, Germany

Protagonist -  William H. Sauer, MD, FHRS, CCDS. University of Colorado, Denver, CO

Antagonist - Atul Verma, MD, FHRS. Southlake Regional Health Centre, Toronto, ON, Canada

Rebuttal - William H. Sauer, MD, FHRS, CCDS. University of Colorado, Denver, CO

Rebuttal - Atul Verma, MD, FHRS. Southlake Regional Health Centre, Toronto, ON, Canada

Optimizing the CRT Patient: Science and Strategies

  • Description
  • CME Info
  • Faculty

This core curriculum session consists of four 20 minute presentations:

  • The Science behind Optimization: Is there a need?
  • ECG Imaging and CRT Optimization 
  • CRT Optimization Using Body Surface Activation Mapping 
  • Automatic Optimization: the Holy grail?

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Chairs 

Angelo Auricchio, MD, PhD. Fondazione Cardiocentro Ticino, Lugano, Switzerland

John N. Catanzaro, MD, FHRS. University of Florida Health -Jacksonville, Jacksonville, FL

Faculty

Frits W. Prinzen, PhD. Maastricht University, Maastricht, Netherlands

Sylvain Ploux, MD. Bordeaux University Hospital (CHU), Pessac, France

Alan J. Bank, MD. United Heart and Vascular Clinic, St. Paul, MN

Peter Paul Delnoy, MD, PhD. Isala Hospital, Zwolle, Netherlands

Pathophysiology and Treatment of Ventricular Arrhythmias in 2018

  • Description
  • CME Info
  • Faculty

This core curriculum session from Heart Rhythm 2018 will provide an overview and update on the pathophysiology underlying ventricular arrhythmias, the indications and outcomes of VT ablation procedures, and a variety of strategies to improve mapping of ventricular arrhythmias within the EP laboratory.

The session is 90 minutes in length and is comprised of four presentations:

  • Idiopathic vs Scar Related Ventricular Arrhythmias: Review of Pathophysiology and Arrhythmia Mechanisms 
  • Indications, Procedure Complications, and Outcomes in PVC and VT Ablation 
  • Tools and Techniques to Optimize VT Ablation: High Resolution Mapping, Hemodynamic Support, and Imaging 
  • PVC-induced Cardiomyopathy: How to Prevent, Predict and Treat

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Chair: Erin E. Flatley, BSN, MSN, NP. University of California San Francisco, San Francisco, CA 
Chair: Hyun-Soo Lee, MPH. Korea Univ Arrhythmia Center, Seoul, SE, Korea, Republic of 
Cory M. Tschabrunn, PhD, CEPS. University of Pennsylvania, Philadelphia, PA 
Jeffrey R. Winterfield, MD, FHRS. Medical University of South Carolina, Mount Pleasant, SC 
Roderick Tung, MD, FHRS. University of Chicago, Chicago, IL 
Venkatakrishna N. Tholakanahalli, MD, FHRS. VA Medical Center, Minneapolis, MN

Pathophysiology and Treatment of Atrial Arrhythmias in 2018

  • Description
  • CME Info
  • Faculty

This core curriculum session from Heart Rhythm 2018 will provide an overview on the pathophysiology of various atrial arrhythmias, an update on pharmacologic management as well as the indications, techniques and outcomes for ablation therapy.

The session is 60 minutes in length consisting of the following 20-minute presentations:

  • Mechanisms and Pathophysiology of Atrial Fibrillation
  • Current Indications, Treatment Strategies, and Outcomes of AF Ablation
  • Multidisciplinary Care of the AF Patient and Relationship to Outcomes 

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Chairs
Laurel M. Taylor, PA, PAC. Brigham & Women's Hospital, Cardiology, Boston, MA
Jill L. Schaeffer, MSN, CRNP, FHRS, CEPS, CCDS. The Heart Group, Stevens, PA

Faculty
Rutuke K. Patel, PAC. Temple University Hospital, Lansdale, PA
Scott J. Cox, MS, PAC, CEPS, CCDS. Main Line Health System, Newtown, PA
Jeroen ML. Hendriks, MS, PhD, RN. Centre for Heart Rhythm Disorders - University of Adelaide, Adelaide, Australia

AF Summit 2018

  • Description
  • CME Info
  • Faculty

The 2018 AF Summit program provides a comprehensive review of atrial fibrillation (AF) ablation and evolving therapies that are shaping the field. 

ACCREDITATION STATEMENT
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 4.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

  • Hugh Calkins, MD, FHRS, CCDS 
  • Jeremy N. Ruskin, MD 
  • Pierre Jais, MD
  • Douglas L. Packer, MD, FHRS 
  • Ulrich Schotten, MD, PhD 
  • Vivek Y. Reddy, MD
  • Shih-Ann Chen, MD
  • Albert L. Waldo, MD, FHRS, CCDS
  • Andrea Natale, MD, FHRS
  • Gerhard Hindricks, MD 
  • Ellen Hoffmann, MD
  • D. Wyn Davies, MD, FHRS
  • David J. Callans, MD, FHRS, CCDS 

 

How I Map Atrial Fibrillation: Cases to Illustrate Competing Approaches

  • Description
  • CME Info
  • Faculty

Confused by the ever-expanding array of mapping tools in AF? Come listen to the experts in the field of AF mapping talk about how they use commercially available technologies in daily practice and how AF mapping develops our knowledge of mechanisms.

ACCREDITATION STATEMENT
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

Meleze Hocini, MD
Boulogne-Billancourt Cedex, France

John M. Miller, MD, FHRS
Indiana Univ School of Medicine, Krannert Institute of Cardiology, Indianapolis, IN

Francis Marchlinski, MD, FHRS
Hospital of the Univ of Pennsylvania, Cardiac Electrophysiology, Bala Cynwyd, PA

Andrea Natale, MD, FHRS
Texas Cardiac Arrhythmia Institute at St. David's Medical Center, Austin, TX

Anticoagulation for AF in 2018: Current Status and Unresolved Issues

  • Description
  • CME Statement
  • Faculty & Disclosures

Anticoagulation for AF in 2018: Current Status and Unresolved Issues

This mini-course provides six presentations that address the physicians understanding of all the benefits and limitations of available anticoagulants for the treatment of Atrial Fibrillation.

Complimentary CME credits - Earn up to 1.75 CME credits 

Learning Objectives

  • To explain how to prescribe anticoagulants appropriately in AF patients.

  • To identify appropriate patients for anticoagulation

  • To outline the best strategy for anticoagulation in patients undergoing CIED implant or AF ablation

  • To recognize the problems with DOAC underdosing and overdosing.

 

ACCREDITATION STATEMENT
The Heart Rhythm Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENT
The Heart Rhythm Society designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The AMA has determined that physicians not licensed in the United States who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.

A Certificate of Participation (for non-physicians) will be provided to individuals seeking credit from the following organizations which accept AMA PRA Category 1 Credit(s)™. Note that participants are advised to contact their certifying body for specific information regarding credit submissions:

  • American Academy of Family Practice (AAFP) for elective credit
  • American Academy of Nurse Practitioners Certification Board (AANPCB)
  • American Academy of Physician Assistants (AAPA)
  • American Nurses Credentialing Center (ANCC)
  • American Osteopathic Association (AOA) for Category 2 credit
  • European Board of Accreditation in Cardiology (EBAC)
  • European CME Credits (ECMEC)

DISCLOSURE OF FACULTY’S COMMERCIAL RELATIONSHIP(S)

It is the policy of the Heart Rhythm Society to ensure balance, independent objectivity, and scientific rigor in all its certified educational activities. Everyone involved in the planning and participation of continuing medical education activities is required to disclose any real or apparent conflicts of interest related to the content in his/her presentation(s) and also disclose discussions of unlabeled/unapproved uses of drugs or devices during his/her presentation(s). Detailed disclosure information will be available prior to the activity and in the activity slides.

Faculty

Joris R. de Groot, MD, PhD
Academic Medical Center
Amsterdam, Netherlands

Cynthia M. Tracy, MD
George Washington Univ Medical Center 
Dept of Cardiology
Washington, DC

Benjamin A. Steinberg, MD, MHS, FHRS
University of Utah Cardiovascular Division
Sandy, UT

Mintu P. Turakhia, MD, MS
Stanford University / Palo Alto VA
Palo Alto, CA

David H. Birnie, MD
Ottawa Heart Institute
Ottawa, ON, Canada

Richard J. Kovacs
Indiana University, IN



Disclosures

Planners –

Michael D. Ezekowitz, MD, PhD 
Compensation for Services; Bayer HealthCare, LLC, Boehringer Ingelheim, Portola Pharmaceuticals Inc., Janssen Pharmaceuticals, Johnson and Johnson, Daiichi, Pfizer, Inc., Bristol Meyers Squibb. 
Research Grants; Pfizer, Inc., Boehringer Ingelheim.

Gerald V. Naccarelli, MD, FHRS
Compensation for Services; OMEICOS Therapeutics, Sanofi Aventis, Novartis Pharmaceuticals Corp., Glaxo Smith Kline Pharmaceuticals (GSK), Janssen Pharmaceuticals.
Research Grants; Janssen Pharmaceuticals


Faculty –

Joris R. de Groot, MD, PhD
Compensation for Services; Bristol Meyers Squibb, St. Jude Medical, Bristol Meyers Squibb, AtriCure, Inc., Daiichi. 
Research Grants; AtriCure, Inc., St. Jude Medical

Cynthia M. Tracy, MD
Nothing to Disclose

Benjamin A. Steinberg, MD, MHS, FHRS
Compensation for Services; Janssen Pharmaceuticals, Bristol Meyers Squibb. 
Speaker's Bureau; Biosense Webster, Inc.
Research Grants; Boston Scientific Corp., Abbott Laboratories

Mintu P. Turakhia, MD, MS
Compensation for Services; Medtronic, Inc., Abbott, Cardiva Medical
Equity Interests/Stock Options – Non-Public; AliveCor, iBeat Inc. 
Research Grants; American Heart Association, Apple, Inc., Janssen Pharmaceuticals, Cardiva Medical, Astra Zeneca Pharmaceuticals, Bristol Meyers Squibb.

David H. Birnie, MD
Research Grants; Boehringer Ingelheim, Medtronic, Inc., Bayer / Schering Pharma, Biotronik. 
Fellowship Support; St. Jude Medical, Biosense Webster, Inc., Medtronic, Inc.

Richard J. Kovacs
Compensation for Services; Jazz Pharmaceuticals, Eli Lilly, Cook Medical, Inc.
Research Grants; SIEMENS

Staff – 
Chloe Thomas – None

Russell Werlinich, CMP - None

Update on Leadless Pacing (as presented at Heart Rhythm 2018)

  • Description
  • Presentations
  • Faculty

Update on Leadless Pacing is comprised of presentations from Heart Rhythm 2018, held May 9 - 12 in Boston, MA.

The ability to pace the ventricle without a lead is only the beginning of a radical change in pacing therapies.  The technology is novel as well as the implanting technique and the follow up.  Also, one of the first leadless pacing technologies lead to an early recall and the reliability of the battery for this technology is undefined.  Lastly, the use of leadless pacing offers new strategies when combined with a subcutaneous ICD and placed in the LV for CRT therapy. These type of expanding indications for leadless pacing will radically change the approach to a broad population of patients.

  • Implantation techniques for safe and successful leadless pacemaker 
  • How to Implant a Leadless Pacemaker Anywhere in the Right Ventricle
  • Worldwide experience of managing a leadless pacemaker recall, extraction and follow up 
  • What have we learnt from the last 5 years of leadless pacing? Live and Learn
  • Tips and tricks for leadless pacemaker extraction 
  • My patient with intermittent complete heart block - leadless pacing or CRT? 
  • A mixed future - Combining S-ICD and leadless pacing 
  • ICD therapy and leadless pacing - initial experience 
  • When Will Leadless Pacing Be Ready For Prime Time in Children and ACHD Patients?

 

Rahul N.. Doshi
University of Southern California Keck School of Medicine

Vivek Y.. Reddy
Icahn School of Medicine at Mount Sinai
New York, NY

Jacob S.. Koruth
Mount Sinai Medical Center

Derek V. Exner, MD, MPH, FHRS
Libin Cardiovascular Institute of Alberta
Calgary, Canada

Mina K.. Chung
Cleveland Clinic
Dept of Cardiovascular Medicine
Cleveland, OH

Lluis Mont, MD, PhD
Cardiovascular Institute - Hospital Clinic
University of Barcelona
Barcelona, Spain

Lucas V. A. Boersma, MD, PhD
St. Antonius Ziekenhuis
Nieuwegein, Netherlands

Ivan Cakulev, MD, FHRS
University Hospitals Cleveland
Div of Medicine, Cardiology
Cleveland, OH

AF Ablation – Pre and Intra Procedure Updates (as presented at Heart Rhythm 2018)

  • Description
  • Presentations
  • Faculty

AF Ablation – Pre and Intra Procedure Updatesy is comprised of presentations from Heart Rhythm 2018, held May 9 - 12 in Boston, MA.

Atrial fibrillation ablation has always been a moving target. There is an excess of data to review from hundreds of trials each year, and as technology continues to provide more and more tools and options, staying current becomes very difficult. This learning objective is intended to review the current state of atrial fibrillation ablation, and provide expert summary to simplify the excess of knowledge available.

Presentations include:

AF Ablation - Pre-Ablation

  • Low Voltage Tissue: Ablate, Encircle or Ignore 
  • Quantifying Atrial Fibrosis in The Electrophysiology Laboratory: The Role of High Density Mapping 
  • Identification of Potential Mechanisms Underlying the Persistence of Atrial Fibrillation: A Cased Based Approach 
  • Ablation of Rotors and Focal Sources Underlying Persistent AF: A Case Based Approach 
  • Subclinical AF in patients without pacemakers and defibrillators - Effective means of risk stratification
  • When do patients with atrial high rate episodes (or 'subclinical' atrial fibrillation) require oral anticoagulation?
  • Pill-in-the-pocket on demand oral anticoagulation - Are we there yet?
  • AF Ablation - Intra-procedure

Catheter Ablation of AF Drivers

  • None Pulmonary Vein Trigger ablation after pulmonary vein isolation to improve Paroxysmal Atrial Fibrillation ablation result
  • Additional sinus rhythm substrate modification beyond pulmonary vein isolation to improve Paroxysmal Atrial Fibrillation ablation result 
  • Non-PV Triggers in AF Ablation: Illustration Cases- How to provoke, Localize, and Ablate
  • Do I Need to Map Atrial Fibrillation? 
  • Impedance Decrease in Predicting Lesion Formation in Radiofrequency Left Atrial Ablation
  • Fire or ICE: Which, When and Who?
  • Catheter Ablation of AF: Lessons Learned 
  • Role of Esophageal Temperature Monitoring During Ablation, and Appropriate Testing if Atrioesophageal Fistula is Suspected

AF Ablation - Pre-Ablation
Thomas Arentz, MD
Herz-Zentrum Bad
Krozingen, Germany

Elad Anter, MD
BIDMC, Cardiology
Boston, MA

Jonathan M. Kalman, MBBS, PhD, FHRS
Royal Melbourne Hospital
Melbourne, Australia

John D. Hummel, MD, FHRS
Ohio State Univ.
Div of Cardiovascular Medicine
Columbus, OH

Andrea M. Russo, MD, FHRS
Director, Electrophysiology and Arrhythmia Services
Cooper University Hospital
Moorestown, NJ

Paulus Kirchhof
Professor
University of Birmingham
Birmingham, United Kingdom

Raghuveer Dendi, MD, FHRS
University of Kansas Hospital
Kansas City, KS

AF Ablation - Intra-Procedure
Andrea Natale, MD, FHRS
Texas Cardiac Arrhythmia Institute at St. David's Medical Center
Austin, TX

Luigi Di Biase, MD, PhD, FHRS
Albert Einstein College of Medicine at Montefiore Hospital
New York, NY

Christopher Piorkowski, MD
University of Dresden - Heart Center
Dresden, Germany

Francis E. Marchlinski, MD, FHRS
Hospital of the Univ of Pennsylvania
Cardiac Electrophysiology
Bala Cynwyd, PA

Saurabh Kumar, MD, PhD
Westmead Hospital
University of Sydney
Westmead, Australia

Alexander Fürnkranz, MD
Düsseldorf University Hospital
Düsseldorf, Germany

Douglas L. Packer, MD, FHRS
Mayo Clinic - St. Mary's Hospital
Rochester, MN

Thomas Deneke, MD, PhD, FHRS
Herz-und Gefiss Klinik GmbH
Cardiology Clinic for Interventional EP
Bad Neustadt, Germany

Global Rhythm Exchange - Highlights from the 1st Annual Physiology of Pacing Symposium

  • Highlights - In case you missed it
  • View Select Sessions Now!
  • Full Program Schedule

The 1st annual Physiology of Pacing Symposium 2017 is designed to provide the practicing clinician with specialization in cardiac electrophysiology with an in-depth understanding of selected, cutting-edge therapies in: 

  • His bundle pacing for narrow QRS patients as a means to prevent heart failure
  • His bundle pacing for wide QRS patients as a meand to achieve cardiac resynchronization 
  • Cardiac resychronization with leadless, multisite, and endocardial technology and strategies


This comprehensive educational symposium strives to educate clinicians with specialization in electrophysiology. The distinguished faculty for this event includes many of the foremost clinicians and experts in the country as well as internationally recognized guest faculty. Through focused didactics, panel discussion, and interactive dialogue, participants will gain both broad perspectives and detailed insights into physiologic pacing techniques and paradigms. Estimated symposium attendance is 105 participants.

 

Program Objectives

  • Outline current and emerging therapies for cardiac pacing with emphasis on physiologic mechanism and responses to cardiac resychronization therapy
  • Review the relationship between electrical stimulation of the heart with mechanics of myocardial contraction
  • Discuss the evolving role of His bundle pacing for standard permanent pacing as well as for cardiac resychronization
  • Review history and recent advances in His bundle pacing and emerging clinical situations and applications in the setting of narrow and wide QRS morphology patients
  • Describe challenges and tricks for implantation technique of permanent His bundle pacemaker
  • Review the relevant anatomy of the membranous septum, conduction system with relation to the right atrium andtricuspid valve
  • Explain the potential role of His bundle pacing for patients with atrial fibrillation
  • Summarize strategies and clinical evidence for the various approache to achieve cardiac resychronization including leadless technology, multisite pacing, and left ventricular endocardial pacing
  • Discuss strategies for improving current technologies and tools for cardiac resychronization

Title: Brief Intro: Welcoming remarks and Talk by Dr. Kenneth Ellenbogen and Dr. Roderick Tung (Duration: 5.57)

Title: His Bundle pacing: An Historical perspective
Faculty: B. Scherlag
Target Audience : Electrophysiologists, but also open for general cardiologists and electrophysiology fellows in training
Duration:15.32

Title: History and rationale for permanent His bundle pacing
Faculty: P. Deshmukh
Target Audience : Electrophysiologists, but also open for general cardiologists and electrophysiology fellows in training
Duration: 17.18

Title: Tips and Tricks for HBP implantation
Faculty: G. Dandamudi & P. Vijayaraman
Target Audience : Electrophysiologists, but also open for general cardiologists and electrophysiology fellows in training
Duration: 23.18

Title: HBP for Narrow QRS and heart block: Who and when?
Faculty: P. Sharma F
Target Audience : Electrophysiologists, but also open for general cardiologists and electrophysiology fellows in training
Duration: 16.58

Title: HBP for ablate and pace: Who, When, and How?
Faculty: W. Huang 
Target Audience : Electrophysiologists, but also open for general cardiologists and electrophysiology fellows in training
Duration: 16.95

Title: Long-term outcomes with HBP
Faculty: F. Zanon
Target Audience : Electrophysiologists, but also open for general cardiologists and electrophysiology fellows in training
Duration: 15.42

Title: HBP for CRT: A crossover study
Faculty: D. Lustgarten
Target Audience : Electrophysiologists, but also open for general cardiologists and electrophysiology fellows in training
Duration: 16.28

To view full session content, please visit the 1st Annual Physiology of Pacing Symposium website.

Heart Rhythm On Demand 2018

  • Description
  • Program Format
  • CME Information

The Heart Rhythm Society's 39th Annual Scientific Sessions showcase the very latest in pacing, defibrillation, clinical arrhythmia management, ablation, pharmacology, genetics, basic science, and health policy - presented by world-renowned scientists, researchers and innovators in the field of cardiac pacing and electrophysiology.

Heart Rhythm 2018 offers a variety of session formats, including Featured Symposia, Core Curricula, Mini-Courses, How-To, Mini-Board Review, Debates, Case-Based Tutorials, Complication Theatre Sessions,Translational EP, Special Sessions, Joint Sessions, Hyde Park Corner, Meet the Experts Luncheon Panels, Abstract Presentations (Innovators, Poster, Oral and Moderated), Pioneers Unplugged, and Rapid Fire.

Continuing education credits are NOT available for this content

Summits On Demand 2018

  • Description
  • CME Information

Summits On Demand from Heart Rhythm 2018 Scientific Sessions includes the Following:

AF Summit provides a comprehensive review AF ablation and evolving therapies that are changing the field. Session topics include the role of the autonomic nervous system in cause and management of AF, the ongoing challenge of longstanding persistent AF, and new technologies for AF ablation. Attendees will leave this session with advanced knowledge of this rapidly evolving field. 

VT/VF Summit provides a state-of-the-art discussion regarding all aspects of managing patients with ventricular arrhythmias.  Ablation of idiopathic VT in unusual anatomic locations, ablation of VT in structural heart disease, and an overview of the current knowledge regarding the sudden cardiac death syndrome will be discussed by experts in this field.

CIED Management Summit - Experts will cover practical aspects of His bundle lead implantation, leadless pacemaker placement, and CS lead and LV endocardial lead implantation. Each attendee will test their skills in recognition and device management again questions selected by the experts to test their skills in the field.

Continuing education credits are NOT available for this content

Default Section Content 3

Global Rhythm Exchange - Highlights From The 12th International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy

  • Highlights - In case you missed it
  • View Select Sessions NOW!
  • Full Program Schedule

The 12th International Symposium on Ventricular Arrhythmias: Pathophysiology & Therapy is hosted by the Department of Medicine, Division of Cardiology,University of Pennsylvania Health System, Philadelphia, PA and the Division of Cardiology, The Mount Sinai Hospital, New York, NY.

View select highlights from the October 13 - 14, 2017 conference - 

 

Program Objectives

Provide a review of new information on the basic pathophysiology of ventricular arrhythmias.

Provide an in-depth understanding of current management strategies used for the care of ventricular arrhythmias in various disease states, including non-pharmacological therapies such as implantable device and catheter ablation techniques.

His Bundle Pacing for Cardiomyopathy Patients: An Alternative to CRT?  (duration <12 minutes)
Kenneth Ellenbogen, MD

Complete Epi-Endo Circuit Delineation of Human VT  (duration <14 minutes)
Roderick Tung, MD

Management of Anticoagulation Issues and Bleeding  (duration <11 minutes)
William G. Stevenson, MD

Flecainide Therapy for PVC-Related Cardiomyopathy  (duration <9 minutes)
David Frankel, MD

Imaging for Risk Stratification for Mild-Moderate LV Dysfunction in NICM  (duration <12 minutes)
Sanjay Prasad, MD

Does ARVC Always Progress? Adverse Remodeling versus More Scar  (duration <13 minutes)
Francis Marchlinski, MD

New Insights from the Hopkins ARVC Registry  (duration <12 minutes)
Hugh Calkins, MD

Anatomy/Ablation of LV Summit VT  (duration <12 minutes)
Samuel Asirvatham, MD

To view full session content, please visit the 12th International Symposium website.

Optimizing CRT and New Advances

  • Description
  • Program
  • Faculty

Cardiac resynchronization therapy (CRT) is more than merely biventricular pacing in patients with ventricular conduction delay and systolic heart failure.  With the introduction of new lead technology and pacing algorithms, prescribing CRT becomes more complex.  Ultimately, the goal is a patient-specific biventricular pacing regimen that optimizes response and clinical care. 

This series of CRT lectures is presented by international experts offering their opinions regarding controversial topics in CRT with the intent to provide a review of the literature as well as helpful guidance for specific challenging clinical scenarios.

HRS Members - Complimentary (after log in)

Non-Members - $29 USD

Learning Pathway presentations* include:

  • Resynchronization Therapy Controversies - Permanent Pacing for Severe Conduction Tissue Disease in Patients with Mild LV Dysfunction: To Resynchronize or Not? – duration total <18 minutes
  • Revisiting CRT in mild heart failure: Long-term outcomes mandate a more aggressive approach–duration < 19 minutes
  • Permanent Pacing in a Patient with High Degree AV Block and Preserved Ejection Fraction: Is CRT the Way to Go? – duration <18 minutes
  • Debate - His Bundle Pacing After AVJ Ablation – duration <45 minutes
  • It's Not All About the Lead: Integrating Programming and New Device Technology – duration <98 minutes
    • The Role of LV-Only Pacing in Improving CRT Outcome – duration <25 minutes
    • Rationale and Methods for Achieving AV and VV Optimization – duration <22 minutes
    • Multisite Pacing Do's & Don’ts – duration <27 minutes
    • Optimal Programming for Shock Reduction in CRT Patients – duration <24 minutes
  • Echocardiography Vs Non-invasive Hemodynamic Optimization of AV and VV delay for Cardiac Resynchronization Therapy: The Prospective, multi-centre, randomized, cross-over, non-inferiority BRAVO study.British Randomized Controlled Trial of AV and VV Optimization ("BRAVO") study – duration <20 minutes
  • Impact of Remote Monitoring on Outcome and Survival in CRT Patients – duration <24 minutes
  • Future Directions in CRT: The Impact of Pacing Site on Outcome – duration <20 minutes
  • Infective Complications of CRT in Responder and Superresponder - Periprocedural Management – duration <25 minutes
  • CRT: Emerging Methods and Technology – duration <34 minutes
    • Wireless LV Endocardial Stimulation for Cardiac Resynchronization: Long-term (12 month) Experience of Clinical Efficacy and Clinical Events from Two Centers – duration <16 minutes
    • Leadless LV endocardial stimulation for CRT: Final Outcomes of the Safety and Performance of Electrodes implanted in the Left Ventricle (SELECT-LV) Study – duration <18 minutes
  • How the Minimally Invasive Surgical Approach Can Get the LV Lead in the Best Location – duration <18 minutes
  • Cardiac Resynchronization Therapy in Patients with Fontan Physiology and Heart Block – duration <13 minutes

*Paticipation only / continuing education credits/points NOT available for this activity

Faculty -
Maurizio Gasparini, MD
Rozzano-Milano
Italy

Anthony S. Tang, MD, FHRS
London, Ontario
Canada

Anne Curtis, MD, FHRS
Buffalo, New York

Kenneth A. Ellenbogen, MD, FHRS
Richmond, Virginia

Jeanne E. Poole, MD, FHRS, CCDS
Seattle, Washington

Marye Gleva, FHRS
St. Louis, Missouri

Christophe Leclercq, MD
Rennes, France

Laurence D. Sterns, MD, FHRS
Victoria, British Columbia,
Canada

Zachary I Whinnett, BMBS, PhD
Rickmansworth, United Kingdom

Niraj Varma, MD, PhD
Cleveland, Ohio

Gery Tomassoni, MD, FHRS
Lexington, Kentucky

Bruce L. Wilkoff, MD, FHRS, CCDS
Cleveland, Ohio

Petr Neuzil, MD, PhD
Prague, Czech Republic

Vivek Y. Reddy, MD
New York, New York

Jamil Bashir, MD
Vancouver, British Columbia Canada

Edward O'Leary, MD
Boston, Massachusetts

View All Activities